Discover an objective suicide risk assessment for patients denying ideation, using Suicide Crisis Syndrome and staged warning signs to guide earlier intervention.
Igor Galynker, MD, PhD
Advertisement
Dr Galynker is the associate chairman for Research in the Department of Psychiatry at Mount Sinai-Behavioral Health Center, and is the founder and director of the Richard and Cynthia Zirinsky Family Center for Bipolar. He is a professor of Psychiatry at the Icahn School of Medicine.
Articles by Igor Galynker, MD, PhD
In this CME article, explore a 4-stage framework that detects suicide risk without ideation disclosure, guiding clinicians to spot crisis signs and act fast.
Fathers share their heartbreaking stories of loss and advocate for a new model of suicide prevention that emphasizes early intervention and awareness at the 2025 APA Annual Meeting.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Developing Next-Generation Psychedelic Treatments: Insights on Bretisilocin From AJ Cannon, MD
2
Artificial Intelligence in Psychopharmacology: Promise and Pitfalls, With Roy Perlis, MD
3
“Engineered Addiction”: Redefining Addictive Disorders and the Psychiatric Impact of Social Media
4
Monoamines: A Full House
5